Discover how PEARL, a cfDNA-based method, enhances early preeclampsia detection, offering safer, non-invasive prenatal ...

Her writing focuses on gene editing technology, cell and gene therapies, and the regulatory space.

A new blood test has an 80% accuracy in predicting preterm preeclampsia, according to a study published today, Feb. 12, in ...

When cell-free DNA is isolated in maternal plasma ... that consequential decisions about a pregnancy should not be made without an invasive test as a follow-up. But this is likely to be a ...

"A lot of immunocompromised patients are not stable enough to undergo these invasive ... More information: Anthony Lieu et al ...

A new blood test is designed to find mold infections deep inside the body, sparing patients from tissue biopsies.

Scientists have developed a breakthrough method to track diet using stool metagenomic data. This non-invasive, data-driven approach offers an objective alternative to traditional food diaries and ...

A new study on circulating tumor DNA (ctDNA) testing for advanced breast cancer has unveiled encouraging results, with high ...

Aldevron, a global leader in the production of DNA, RNA and protein, has launched its latest innovation, Alchemy™ cell-free DNA technology. This revolutionary technology represents a significant ...

Minimally invasive genomic sequencing of circulating tumor DNA (ctDNA) can be performed using ... in patients after definitive radical surgery, did not meet its primary end point of disease-free ...